We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Targeting Tumors: Challenges of Antibody-Drug Conjugates

Video   Jun 12, 2018 | Nature Video, YouTube

 

Treating cancer requires aggressive but targeted therapy. Some cancer drugs are too toxic because they damage healthy cells as well as tumor cells. So researchers are trying to develop ways to make sure drugs only target the right cells.

One solution is to attach drugs to antibodies specific to a protein expressed on tumor cells. These drugs are called antibody-drug conjugates (ADCs).

More than two dozen ADCs are currently being used in the clinic to treat diseases like Hodgkin's lymphoma and breast cancer, and researchers are developing many more. But it's taken decades to find the right combination of drug, antibody target and linker, and then make sure the right amount of ADC hits the tumor. 


 
More Information
 
 
 

Recommended Videos

Ready for a change of scenery?

Video

Get a new perspective on your sample QC with the Agilent 4150 TapeStation system and open up new horizons. Ideal for handling smaller numbers of samples, the system with ScreenTape assays delivers fast, reliable results within any NGS workflow.

WATCH NOW

The Advantages of Machine Learning and Artificial Intelligence in the Drug Discovery Process

Video

Dr Ola Engkvist, AstraZeneca, explains how the drug discovery process benefits from artificial intelligence and machine learning.

WATCH NOW

Cell Culture Basics

Video

An overview of aseptic techniques

WATCH NOW

 

Like what you just watched? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE